1800 103 7100
info@mohanfoundation.org
MOHAN Foundation

Menu

Skip to content
  • About
  • Free Downloads
  • Videos

Life...

Let's Pass it on...

Know More

Organs wasted are lives lost....

Become an Organ Donor-Saves Lives...

Know More

Don't Take your organs to Heaven...

Know More

Organ Donation

If you save one life,It is as though you save the world

14Feb/12

How To Increase Organ Donor Numbers, BMA Asks, UK – Medical News Today

February 14, 2012Organ Donoradmin

BBC NewsHow To Increase Organ Donor Numbers, BMA Asks, UKMedical News TodayAccording to the BMA report "Building on Progress: Where next for organ donation policy in the UK?", people will still continue to die needlessly whilst waiting for an…

14Feb/12

What's Making My Nipple Itch? Part II – WebMD (blog)

February 14, 2012Immunosuppressive Drugsadmin

What's Making My Nipple Itch? Part IIWebMD (blog)When other causes have been ruled out a steroid cream/ointment, or tacrolimus, may be prescribed. Another common cause of itchy, inflamed skin is Seborrheic Dermatitis (SD). It particularly targets u…

14Feb/12

Doctors testify in Livezey hearing – Calaveras Enterprise

February 14, 2012Brain Death Declarationadmin

Doctors testify in Livezey hearingCalaveras EnterpriseWhen Matthews asked Jacobson if he thought the broken neck caused the brain death, Jacobson said that it could lead to respiratory failure, which could lead to cardiac arrest that could lead to brai…

14Feb/12

Biogen Idec to buy Stromedix for up to $562M – Mass High Tech

February 14, 2012Chronic Allograft Nephropathyadmin

Biogen Idec to buy Stromedix for up to $562MMass High TechIn August 2008, Stromedix won orphan drug status from the US Food and Drug Administration for STX-100, as a treatment for chronic allograft nephropathy, a cause of transplant failure in patients…

14Feb/12

Hematologic Cancers in Pregnancy Pose Substantial Risks – Medscape

February 14, 2012Monoclonal Anti-CD20 Antibodiesadmin

Hematologic Cancers in Pregnancy Pose Substantial RisksMedscape"In contrast, aggressive lymphomas should be treated with no delay, and can be managed relatively safely by administrating the CHOP [cyclophosphamide, doxorubicin, vincristine, and pre…

14Feb/12

Biogen Idec Chief George Scangos Among 25 Most Influential People in Biopharma … – Citybizlist (press release)

February 14, 2012Monoclonal Anti-IL-2Rα Receptor Antibodiesadmin

Citybizlist (press release)Biogen Idec Chief George Scangos Among 25 Most Influential People in Biopharma …Citybizlist (press release)based company's "stock took off last year, fueled by positive data on key experimental therapies such as th…

14Feb/12

Orders on Cadaver Transplantation Programme issued – The Hindu

February 14, 2012Brain Death Declarationadmin

Orders on Cadaver Transplantation Programme issuedThe HinduThe order specifies norms and procedures for determining brain death and gives legal backing for the organ transplantation. Issued under the Transplantation of Human Organs Act 1994, the order …

14Feb/12

Abbott's Tacrolimus assay provides consistent medication monitoring for organ … – News-Medical.net

February 14, 2012Immunosuppressive Drugsadmin

Abbott's Tacrolimus assay provides consistent medication monitoring for organ …News-Medical.netA new study published in the journal Clinical Chemistry reported Abbott's (NYSE: ABT) ARCHITECT® Tacrolimus assay provides accurate and consistent…

14Feb/12

Procoralan® Receives European Approval for Use in Heart Failure – SYS-CON Media (press release)

February 14, 2012Organ Failureadmin

Procoralan® Receives European Approval for Use in Heart FailureSYS-CON Media (press release)Servier today announced that the company's heart rate lowering agent, ▼Procoralan® (ivabradine), the first selective I f channel inhibitor, has been app…

14Feb/12

In Vivo Studies Show CD137 mAb Agonist Boosts Anticancer Activity of Trastuzumab – Genetic Engineering News

February 14, 2012Monoclonal Anti-CD20 Antibodiesadmin

In Vivo Studies Show CD137 mAb Agonist Boosts Anticancer Activity of TrastuzumabGenetic Engineering NewsRather, the CD137 agonist boosted the ability of NK cells activated using trastuzumab-coated breast cancer to kill rituximab-coated lymphoma cells. …

Posts navigation

  • « Previous
  • 1
  • …
  • 17,781
  • 17,782
  • 17,783
  • 17,784
  • 17,785
  • …
  • 18,199
  • Next »

Categories

  • Antibodies
  • Blood donation
  • Bone marrow donation and transplantation
  • Brain Death Declaration
  • Chronic Allograft Nephropathy
  • Donor Card
  • Drugs/Medicine
  • Google News RSS feed URL deprecation
  • Heart
  • HLA Typing
  • Immunosuppressive Drugs
  • Infectious Disease
  • Intestinal
  • Islet
  • Kidney
  • Liver
  • Lung
  • Monoclonal Anti-CD20 Antibodies
  • Monoclonal Anti-IL-2Rα Receptor Antibodies
  • Nephrology
  • Organ Donation
  • Organ Donor
  • Organ Failure
  • Organ Preservation Methods
  • Organ Preservation Solution
  • Organs
  • Other Transplantation
  • Pancreas
  • Pharma News
  • Polyclonal Anti-T-Cell Antibodies
  • Tissue Donation
  • Transplant laws
  • Transplant Rejection
  • Transplant Studies
  • Transplant Surgery
  • Transplant Tourism
  • Transplant Trials
  • Transplantation
  • Uncategorized
Copyright © MOHAN Foundation
Powered by WordPress , Theme i-excel by TemplatesNext.
MENU
    • About
    • Free Downloads
    • Videos